About this trial
This study aims to determine whether combining aggressive intravenous hydration with indometacin is more effective at preventing pancreatitis after a Extracorporeal Shock Wave Lithotripsy (ESWL) than using indometacin alone.
The study will involve patients who are scheduled to undergo ESWL for pancreatic stones. Participants will be randomly assigned to one of two groups: one will receive both the intravenous hydration and the rectal indometacin, while the other will receive only the rectal indometacin.
The trial will be conducted at multiple centers, ensuring a broad and diverse patient population.
The primary outcome of the study will be the incidence of pancreatitis after the ESWL procedure.
This study is important because it could lead to a better understanding of how to prevent pancreatitis after ESWL, potentially improving patient outcomes and reducing the risk of serious complications.
Eligibility criteria
Qualifiers
Patients with painful chronic pancreatitis eligible for P-ESWL treatment
Ages between 18-85 years
Providing informed consent
Disqualifiers
Patients readmitted to the hospital for ESWL during the study period
contraindications to ESWL
Signs of congestive heart failure, such as pitting edema or a New York Heart Association classification greater than class I heart failure. For patients ≥ 70 years old, brain natriuretic peptide (BNP) and cardiac ultrasound would be performed before ESWL. Patients with BNP>100pg/ml or Ejection Fraction value<50% should be excluded
Respiratory insufficiency (pO2 < 60 mmHg or saturation < 90% despite FiO2 of 30% or requiring mechanical ventilation). For patients ≥ 70 years old, pulmonary function tests would be performed before ESWL. Patients with Forced Expiratory Volume in the first second (FEV1) <70% are excluded
Trial design
Treatments tested in this trial
- Indometacin suppository
- Lactated ringers solution
- Normal Saline
Treatment groups
Sponsors and collaborators
Changhai Hospital
Lead sponsor
Ruijin Hospital
Collaborator
LanZhou University
Collaborator
First People's Hospital of Hangzhou
Collaborator
The Second Affiliated Hospital of Baotou Medical College
Collaborator
Shanghai Pudong New Area Gongli Hospital
Collaborator
Peking Union Medical College Hospital
Collaborator
Qilu Hospital of Shandong University
Collaborator
The Third Xiangya Hospital of Central South University
Collaborator
Affiliated Hospital of Yunnan University
Collaborator